 Connection
Victoria Pelak to Humans
This is a "connection" page, showing publications Victoria Pelak has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.423 |
|
|
|
-
Pelak VS, Krishnan V, Serva S, Pressman P, Mahmood A, Noteboom L, Bettcher BM, Sillau SH, Callen AL, Thaker AA. Lobar Microbleeds in the Posterior Cortical Atrophy Syndrome: A Comparison to Typical Alzheimer's Disease. Curr Neurol Neurosci Rep. 2024 Feb; 24(2):27-33.
Score: 0.026
-
Pelak VS, Mahmood A, Abe-Ridgway K. Perspectives and a Systematic Scoping Review on Longitudinal Profiles of Posterior Cortical Atrophy Syndrome. Curr Neurol Neurosci Rep. 2022 Nov; 22(11):803-812.
Score: 0.023
-
Pelak VS, Paez YM, Patnaik JL, Holden SK, Subramanian PS, Mathias MT, Mandava N, Lynch AM. An Exploratory Study to Investigate the Utility of Clinical Screening for Neurodegenerative Disease in Age-Related Eye Disease Research. J Neuroophthalmol. 2022 09 01; 42(3):346-352.
Score: 0.023
-
Pelak VS. The clinical approach to the identification of higher-order visual dysfunction in neurodegenerative disease. Curr Neurol Neurosci Rep. 2022 04; 22(4):229-242.
Score: 0.023
-
Hall DA, Leehey MA, Hagerman RJ, Pelak VS. Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome. J Neuroophthalmol. 2021 12 01; 41(4):e661-e664.
Score: 0.022
-
Pelak VS. An Older Patient With Difficulty Reading. J Neuroophthalmol. 2021 Sep 01; 41(3):e414.
Score: 0.022
-
Hixon AM, Thaker AA, Pelak VS. Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: Case series and literature review. Eur J Neurol. 2021 10; 28(10):3289-3302.
Score: 0.021
-
Martin Paez Y, Bennett JL, Subramanian PS, Pelak VS. Considerations for the Treatment of Inflammatory Neuro-Ophthalmologic Disorders During the COVID-19 Pandemic. J Neuroophthalmol. 2020 09; 40(3):305-314.
Score: 0.020
-
Holden SK, Bettcher BM, Pelak VS. Update on posterior cortical atrophy. Curr Opin Neurol. 2020 02; 33(1):68-73.
Score: 0.019
-
Bou Ghannam AS, Mehner LC, Pelak VS. Sialidosis Type 1 Without Cherry-Red Spot. J Neuroophthalmol. 2019 09; 39(3):388-390.
Score: 0.019
-
Pelak VS. The Visual Snow Conference: May 5, 2018, University of California San Francisco. J Neuroophthalmol. 2018 09; 38(3):e17-e18.
Score: 0.018
-
Pelak VS, Hills W. Vision in Alzheimer's disease: a focus on the anterior afferent pathway. Neurodegener Dis Manag. 2018 02; 8(1):49-67.
Score: 0.017
-
Hua JT, Hildreth KL, Pelak VS. Effects of Testosterone Therapy on Cognitive Function in Aging: A Systematic Review. Cogn Behav Neurol. 2016 Sep; 29(3):122-38.
Score: 0.015
-
Pelak VS, Smyth SF, Boyer PJ, Filley CM. Computerized visual field defects in posterior cortical atrophy. Neurology. 2011 Dec 13; 77(24):2119-22.
Score: 0.011
-
Pelak VS. Ocular motility of aging and dementia. Curr Neurol Neurosci Rep. 2010 Nov; 10(6):440-7.
Score: 0.010
-
Athappilly G, Pelak VS. Teaching neuroimages: Superior segmental optic nerve hypoplasia confirmed by optical coherence tomography. Neurology. 2009 May 05; 72(18):e91-2.
Score: 0.009
-
Nguyen LT, Taravella MJ, Pelak VS. Determining whether delayed nonarteritic ischemic optic neuropathy associated with cataract extraction is a true entity. J Cataract Refract Surg. 2006 Dec; 32(12):2105-9.
Score: 0.008
-
Pelak VS, Hall DA. Neuro-ophthalmic manifestations of neurodegenerative disease. Ophthalmol Clin North Am. 2004 Sep; 17(3):311-20, v.
Score: 0.007
-
Chapleau M, La Joie R, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BDC, Crutch S, Filippi M, Fumagalli GG, Galimberti D, Graff-Radford J, Grinberg LT, Irwin DJ, Josephs KA, Mendez MF, Mendez PC, Migliaccio R, Miller ZA, Montembeault M, Murray ME, Nemes S, Pelak V, Perani D, Phillips J, Pijnenburg Y, Rogalski E, Schott JM, Seeley W, Sullivan AC, Spina S, Tanner J, Walker J, Whitwell JL, Wolk DA, Ossenkoppele R, Rabinovici GD. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol. 2024 Feb; 23(2):168-177.
Score: 0.006
-
Thaker AA, McConnell BV, Rogers DM, Carlson NE, Coughlan C, Jensen AM, Lopez-Paniagua D, Holden SK, Pressman PS, Pelak VS, Filley CM, Potter H, Solano DA, Heffernan KS, Bettcher BM. Astrogliosis, neuritic microstructure, and sex effects: GFAP is an indicator of neuritic orientation in women. Brain Behav Immun. 2023 10; 113:124-135.
Score: 0.006
-
Abraham AG, Hong C, Deal JA, Bettcher BM, Pelak VS, Gross A, Jiang K, Swenor B, Wittich W. Are cognitive researchers ignoring their senses? The problem of sensory deficit in cognitive aging research. J Am Geriatr Soc. 2023 05; 71(5):1369-1377.
Score: 0.006
-
Holden SK, Pelak VS, Sooy T, Heffernan KS, McConnell BV, Pressman PS, Bettcher BM. Development of the Colorado posterior cortical questionnaire within an Alzheimer's disease study cohort. J Clin Exp Neuropsychol. 2022 04; 44(3):226-236.
Score: 0.006
-
Kletenik I, Ferguson MA, Bateman JR, Cohen AL, Lin C, Tetreault A, Pelak VS, Anderson CA, Prasad S, Darby RR, Fox MD. Network Localization of Unconscious Visual Perception in Blindsight. Ann Neurol. 2022 02; 91(2):217-224.
Score: 0.006
-
Bennett JL, Pelak VS. Palsies of the third, fourth, and sixth cranial nerves. Ophthalmol Clin North Am. 2001 Mar; 14(1):169-85, ix.
Score: 0.005
-
Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 07 14; 95(2):e111-e120.
Score: 0.005
-
Pelak VS, Bolinger L, Galetta SL, Butler N, Stein A, Liu GT. 4.0 Tesla magnetic resonance imaging of brainstem lesions with ocular motility deficits. J Neuroophthalmol. 2000 Jun; 20(2):135-7.
Score: 0.005
-
Potter H, Boyd TD, Clarke P, Pelak VS, Tyler KL. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19. F1000Res. 2020; 9:345.
Score: 0.005
-
Pelak VS, Galetta SL, Grossman RI, Townsend JJ, Volpe NJ. Evidence for preganglionic pupillary involvement in superficial siderosis. Neurology. 1999 Sep 22; 53(5):1130-2.
Score: 0.005
-
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimers Res Ther. 2019 03 13; 11(1):23.
Score: 0.005
-
Pressman PS, Gola K, Shdo SM, Miller BL, Fredericks C, Mielke C, Pelak V, Rankin KP. Relative preservation of facial expression recognition in posterior cortical atrophy. Neurology. 2019 03 05; 92(10):e1064-e1071.
Score: 0.005
-
Chen JJ, Flanagan EP, Jitprapaikulsan J, L?pez-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 11; 195:8-15.
Score: 0.004
-
Berliner JM, Kluger BM, Corcos DM, Pelak VS, Gisbert R, McRae C, Atkinson CC, Schenkman M. Patient perceptions of visual, vestibular, and oculomotor deficits in people with Parkinson's disease. Physiother Theory Pract. 2020 Jun; 36(6):701-708.
Score: 0.004
-
Jones W, Silkworth W, Dusto N, Pelak VS, Berliner J, Buard I, Kluger B. Central Visual Oscillopsia: Case Report and Review of the Literature. Cogn Behav Neurol. 2018 06; 31(2):86-95.
Score: 0.004
-
Yin D, Thompson JA, Drees C, Ojemann SG, Nagae L, Pelak VS, Abosch A. Optic Radiation Tractography and Visual Field Deficits in Laser Interstitial Thermal Therapy for Amygdalohippocampectomy in Patients with Mesial Temporal Lobe Epilepsy. Stereotact Funct Neurosurg. 2017; 95(2):107-113.
Score: 0.004
-
Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Su?rez Gonz?lez A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017 Aug; 13(8):870-884.
Score: 0.004
-
Kumpe DA, Seinfeld J, Huang X, Mei Q, Case DE, Roark CD, Subramanian PS, Lind KE, Pelak VS, Bennett JL. Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting. J Neurointerv Surg. 2017 Sep; 9(9):867-874.
Score: 0.004
-
Nanji AA, Klein KS, Pelak VS, Repka MX. Nonarteritic anterior ischemic optic neuropathy in a child with optic disk drusen. J AAPOS. 2012 Apr; 16(2):207-9.
Score: 0.003
-
Jin M, Pelak VS, Curran T, Nandy RR, Cordes D. A preliminary study of functional abnormalities in aMCI subjects during different episodic memory tasks. Magn Reson Imaging. 2012 May; 30(4):459-70.
Score: 0.003
-
Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012 Mar; 116(3):538-48.
Score: 0.003
-
Jin M, Pelak VS, Cordes D. Aberrant default mode network in subjects with amnestic mild cognitive impairment using resting-state functional MRI. Magn Reson Imaging. 2012 Jan; 30(1):48-61.
Score: 0.003
-
Athappilly G, Pelak VS, Mandava N, Bennett JL. Ischemic optic neuropathy. Neurol Res. 2008 Oct; 30(8):794-800.
Score: 0.002
-
Oskarsson B, Pelak V, Quan D, Hall D, Foster C, Galetta S. Stiff eyes in stiff-person syndrome. Neurology. 2008 Jul 29; 71(5):378-80.
Score: 0.002
-
Quan D, Pelak V, Tanabe J, Durairaj V, Kleinschmidt-Demasters BK. Spinal and cranial hypertrophic neuropathy in multiple sclerosis. Muscle Nerve. 2005 Jun; 31(6):772-9.
Score: 0.002
-
Gregory DG, Pelak VS, Bennett JL. Diffusion-weighted magnetic resonance imaging and the evaluation of cortical blindness in preeclampsia. Surv Ophthalmol. 2003 Nov-Dec; 48(6):647-50.
Score: 0.002
-
Balcer LJ, Baier ML, Pelak VS, Fox RJ, Shuwairi S, Galetta SL, Cutter GR, Maguire MG. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler. 2000 Jun; 6(3):163-71.
Score: 0.001
-
Heller R, O'Connell R, Lim L, Aggrawal A, Nogueira A, Alvares Salis LH, Jialiang W, Qian W, Kuaban C, Muna W, Khedr S, Prasad K, Joshi P, John KR, Mathai D, Roxas A, Donaldo M, Poungvarin N, Silberberg D, Pack A, Pelak V, Matenga J, Noguira A. Variation in in-patient stroke management in ten centres in different countries: the INCLEN multicentre stroke collaboration. J Neurol Sci. 1999 Aug 01; 167(1):11-5.
Score: 0.001
-
Biassoni R, Ferrini S, Prigione I, Pelak VS, Sekaly RP, Long EO. Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cells. Scand J Immunol. 1991 Mar; 33(3):247-52.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|